Quantcast
Close Window
   
Welcome :o)
Welcome to another year exposing the harms of Johnson & Johnson products and the executives that care more about money than human health...
 
There really is a highly effective way to put an end to mass tort lawsuits: GET JOHNSON & JOHNSON AND SUBSIDIARY KNOWN DEFECTIVE, HARMFUL AND/OR TOXIC PRODUCTS OFF THE GLOBAL MARKET
 
This work is 100% independent. I am NOT a victim, NOT a lawyer, NOT paid by anyone other than visitors to the site. And no, I do not own any stock in Johnson & Johnson.
 
Emily.
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Glad to see you :o)
March 2017 marks FIVE YEARS of work exposing harm, corruption and massive costs of flood of KNOWN HARMFUL Johnson & Johnson products.
 
This web site currently has the attention of:
click link to validate IP address through whatismyipaddress.com
 
US GOVERNMENT:
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
 
GLOBAL FINANCIAL INSTITUTIONS:
...including many Johnson & Johnson shareholders ;o)
 
Vanguard
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
I am not paid by lawyers, doctors, etc - ONLY by visitors to the web site, the PEOPLE I am working for, PEOPLE like you. Currently reduced to only a part-time job, I donate the remainder of my time to take care of all the work involved in maintaining the site by doing the research, search engine optimized content, responding to victim emails and social media to create awareness among consumers to prevent new injuries as well as continue increasing awareness among Johnson & Johnson shareholders and global health organizations. Feel free to browse list of notable visitors to the web site.
 
God Bless You and Yours and keep you safe from harm,
Emily
 
Please send financial support to keep this very important GLOBAL consumer safety effort going...
 
Enter any amount in GiftBox below or PayPal to Email:
 
emily@johnsonandtoxin.com
 
$.00   
 
Sponsored in part by...
Examining Medicine An in-depth comprehensive, frequently updated look at extreme risks and permanent brain damage caused by psychiatric drugs.
----- / / -----
Fiddaman Blog Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
----- / / -----
Special Needs Advocate Power Join me as we work hard to ensure what our very special children need.

Letters to Johnson and Johnson Shareholders
Collection of letters sent to Johnson & Johnson shareholders and/or posted on the web site and shared.

Keywords: jnj, jpmorgan, vanguard, Deutsche Bank, Janus Capital, letter, stock, shareholder
Date Created/Edited: Updated as needed.
 

Special Sections....
 
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
The Fastest Growing Segment of Johnson & Johnson Is... (2016, November 15)
Growing over 29% in 2016, this is definitely the fastest growing segment of Johnson & Johnson!
johnson & johnson, J&J, JNJ, 2016, lawsuit, lawsuits, tort, liability
 
Third Quarter 2016 Lawsuits Against Johnson & Johnson Still Exploding! Now 99,000! (2016, November 15)
Growing every quarter, lawsuits against Johnson & Johnson in United States alone are now well over 99,000.
talc, risperdal, asr, hip, baby powder, tvt, mesh, lawsuit
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Wealthy Most at Risk for Harm by Johnson & Johnson and Subsidiary Products (2016, August 22)
If you make over $100,000 a year, you are far more likely than lower incomes to become a victim of a Johnson & Johnson and/or subsidiary product.
healthcare, cost, co-pay, risk, deductable, insurance, victim, salary
 
Second Quarter 2016 Lawsuits Against Johnson & Johnson Leap Again From 82,200 to 90,700 (2016, August 4)
Growing every quarter, lawsuits against Johnson & Johnson in United States alone are now well over 90,700.
talc, risperdal, asr, hip, baby powder, tvt, mesh, lawsuit
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
Johnson and Johnson Janssen Xarelto Slaughter (2016, July 8)
Overstating benefits, downplaying (or not disclosing) risks. Xarelto by Johnson and Johnson Janssen killing people left and right. Over 500 DEAD, 7,100 lawsuits already. Lovely, eh?
false, marketing, death, dead, xarelto, FDA, lawsuit, Janssen
 
This Convinced THREE Juries That Johnson and Johnson Talc Increases Ovarian Cancer (2016, May 14)
One very simple fact convinced THREE juries that Johnson & Johnson talc increases risk of developing ovarian cancer.
Johnson and Johnson, Johnson & Johnson, baby, powder, cancer, lawsuit, ovarian, talc
 
List of letters sent to Johnson & Johnson shareholders and/or posted on the site and shared:
 
Recent Content....
Second Quarter 2016 Lawsuits Against Johnson & Johnson Leap Yet Again From 82,200 to 90,700 (2016, August 9)
Growing every quarter, lawsuits against Johnson & Johnson in United States alone are now well over 90,700.
talc, risperdal, asr, hip, baby powder, tvt, mesh, lawsuit
 
First Quarter 2016 Lawsuits Against Johnson & Johnson Leap Again From 76,400 to 82,200 (2016, May 13)
Growing every quarter, lawsuits against Johnson & Johnson in United States alone are now well over 82,200.
levaquin, risperdal, asr, hip, transvaginal, tvt, mesh, lawsuit
 
2016 Consumer Letter to Johnson & Johnson Shareholders (2016, April 28)
Here we go with another Johnson and Johnson Annual Bullshitting of the Shareholders. I have a list of questions shareholders should consider asking Johnson & Johnson executives. (Post-meeting comments added.)
johnson and johnson, jnj, j&j, 2016, annual, shareholder, meeting, letter
 
2016 Johnson and Johnson US Lawsuit Update: Jump from 56,500 to 76,400 (2016, March 29)
Yet another year of a dramatic increase in lawsuits against Johnson & Johnson and subsidiaries in a lot of countries over a variety of products, and don't include many products with legal action pending.
levaquin, risperdal, asr, hip, transvaginal, tvt, mesh, lawsuit
 
How Johnson & Johnson is Screwing Their Institutional Shareholders (2015,October 22)
Multiply number of shares by $3. Subtract 50% of foreclosure losses, 60% of bankruptcies, percentage of loan defaults due to injuries caused by a Johnson & Johnson or subsidiary product. Hm. Probably looks like Johnson & Johnson crappy products are costing your financial instituation a LOT of money ;o)
alex, gorsky, johnson & johnson, jnj, stock, institutional, shareholder, invest
 
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500 (2015, April 23)
Take a look: Yet another year of a dramatic increase in lawsuits against Johnson & Johnson and subsidiaries over a variety of products.
levaquin, risperdal, asr, hip, transvaginal, tvt, mesh, lawsuit
 
2015 Johnson & Johnson Shareholder Letter (2015, April 2)
It's time to stop investing in healthcare and start investing in #CareOfHealth.
healthcare, letter, johnson & johnson, JNJ, investing, shareholder, 2015, stock
 
Honoring Request to Say Something Nice About Johnson & Johnson (2015, March 27)
Three people requested that I be 'fair' and say something good about Johnson & Johnson. Okay, there is something I'd like to congratulate them on for a Job Very Well Done :o)
fraud, corrupt, effective, marketing, advertising, promtion, plan, strategy
 
Johnson & Johnson Financial BS Officer, I mean Vice Prez of Finance and Chief Financial Officer, Dominic Caruso (2015, February 2)
Our buddy Dom's career includes highlights such as 30% physician kickback for prescribing Remicade, allowing McNeil fall into filth and rubble to be shut down by FDA, massive recalls due to his obvious inability to manage a business.
dominic, caruso, johnson & johnson, chief, financial, finance, centocor, remicade
 
A Strong Argument Against Johnson & Johnson Control of Vaping or E-Cigs (2014, December 9)
Known harmful, misrepresented drugs. Known harmful, misrepresented devices. Known toxic ingredients in baby products. Do NOT let Johnson & Johnson get control of vaping or e-cigs.
vape, vaping, vaper, e-cig, control, regulation, smoking, health
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014 (2014, November 26)
Johnson & Johnson CEO Gorsky claims that high drug costs are due to high costs of drug development. Uh, but TAXPAYERS pay for drug development by funding grants for the National Institutes of Health.
taxes, drug, development, gorsky, pharma, pharmaceutical, grant, 2014
 
Obama Implements J&J CEO Gorsky Healthcare Cost Control Strategy (2014, October 12)
Check out this clip of Johnson & Johnson CEO Alex Gorsky discussing his vision for controlling healthcare costs.
healthcare, obamacare, corruption, cost, increase, insurance, health, gorsky
 
Johnson & Johnson Global Lawsuit Update: 48,500 and Skyrocketing (2014, September 18)
Take a look at the cost of more than 48 thousand US lawsuits pending against Johnson & Johnson.
levaquin, risperdal, asr, hip, transvaginal, tvt, mesh, lawsuit
 
2014 Johnson & Johnson Shareholder Letter (2014, April 15)
Help end out of control corruption in the healthcare industry which allows harmful products to reach consumers, driving up healthcare costs and harming hundreds of thousands of people. Are you or a loved one their next victim?
healthcare, corruption, johnson & johnson, j&j, gorsky, shareholder, 2014, stockt
 
Johnson & Johnson Dominic Caruso: SAVE MONEY! FIRE GORSKY! (2014, February 16)
Johnson & Johnson Dominic Caruso stated that J&J will again restructure and cut jobs to save money. How about firing the CEO, Alex Gorsky, the BIGGEST financial drain on J&J!
alex gorsky, gorsky, CEO, dominic, caruso, doug, douglas, chia
 
Letter to CitiCorp Matthew Dodds RE: $JNJ 3rd quarter 2013 Conference Call (2013, October 16)
Since Orsinger danced around issues causing delays in completion of Synthes acquisition and basically said nothing, I figured I'd give him a real answer.
johnson & johnson, JNJ, j&j, matthew dodds, citicorp, financial analyst, orsinger
 
Letter to J P Morgan Michael Weinstein RE: $JNJ 3rd quarter 2013 Conference Call (2013, October 16)
Since Orsinger and Caruso danced around issues of price competition and lack of consumer sales growth and basically said nothing, I figured I'd give him a real answer.
obama, Michael Weinstein, jp morgan, JNJ, invest, stock, financial, analyst
 
Johnson & Johnson Pacifies Shareholder Lawsuit with Pathetic $23 Million (2013, July 19)
Shareholders filed a lawsuit against JNJ in December of 2010. Three years later, Johnson & Johnson pacified shareholders with a pathetic $23 million settlement without having to admit to wrongdoing.
jnj, johnson and johnson, johnson & johnson, J&J, insider, trading, lawsuit shareholder
 
Insiders and Berkshire Dump Johnson & Johnson JNJ Stock (2013, July 18)
Insider trading shows JNJ management selling and no buying for years and Berkshire dumped all of JNJ stock. Gee, wonder why? Maybe corruption, lawsuits, recalls and toxic products? Nah...
jnj, johnson and johnson, johnson & johnson, J&J, insider, trading, berkshire
 
List of Reasons Johnson & Johnson CEO Alex Gorsky Should Immediately Resign (2013, May 8)
Johnson & Johnson CEO Alex Gorsky isn't part of the solution to the problems facing JNJ, he's the cause of the worst of them.
jnj, johnson and johnson, johnson & johnson, J&J, alex, gorsky, resign, corruption
 
Johnson & Johnson CEO Alex Gorsky's Career Long Cloud of Corruption (2012, November 9)
Bribery, hiding risks, withholding safety date from the FDA, false and misleading marketing in violation of FDA regulations, and so much more corruption - with one man always involved: Alex Gorsky.
jnj, johnson and johnson, johnson & johnson, J&J, alex, gorsky, salary, corruption
 
JNJ Stock: Big Boys Bailing, Not Buying (2012, November 6)
Insider trading shows all selling and no buying and Berkshire dumped almost a third of JNJ stock. Gee, wonder why?
jnj, johnson and johnson, johnson & johnson, J&J, insider, trading, berkshire
 
Skyrocketing Healthcare Costs are Driving 60% of Bankruptcies (2012, October 28)
I wonder when the banks will realize that the pharmaceutical industry got their money and they got the bankruptcy debt.
rising, healthcare, costs, foreclosure, economic, crisis, economy, health
 
Rising Health Care Costs Fueling 50% of Foreclosures and Economic Crisis (2012, October 27)
I wonder when the banks will realize that the pharmaceutical industry got their money and they got the foreclosure debt.
rising, healthcare, costs, foreclosure, economic, crisis, economy, health
 
Johnson & Johnson Retired CEO Weldon Gets $143.5 M for Retirement, $1 M Salary and Bonuses? (2012, May 11)
Okayyy, how about the high cost of healthcare? R&D? Yeah, right.
jnj, johnson and johnson, compensation, J&J, Weldon, CEO, pay, salary
 
Johnson & Johnson Credo Analysis (2012, April 8)
The Johnson & Johnson Credo sounds good, but is nothing more than a fairy tale since it certainly is not used as a guide for ethical business decisions.
jnj, johnson and johnson, johnson + johnson, J&J, credo, analysis, statement, review
 
The High Cost to EVERY American of Corruption at Johnson & Johnson (2012, April 3)
J&J has only *one* source of income: your wallet. The DOJ has only *one* source of income: your wallet. So, our wallets buy the products, pay insurance companies, pay to prosecute J&J, pay to defend J&J and then pay the fines. Everybody say: NO MORE! (tears)
jnj, johnson and johnson, johnson + johnson, J&J, health, care, healthcare
 
Johnson & Johnson Appears to Have More Lawsuits than Drugs in Their Pipeline (2012, March 23)
The number of lawsuits against Johnson & Johnson continues to grow. Everything from faulty hips to baby carcinogens to vaginal mesh - the list of lawsuits may finally outweigh profits.
jnj, johnson and johnson, johnson and toxin, JNTNews, johnson and johnsons, lawsuit, litigation, Gorsky, Weldon
 
Response to Bill Weldon About Bad Asbury Park Press (2012, March 22)
Bill Weldon This is my interpretation and response to the letter sent by William Weldon, the $29 million CEO of Johnson and Johnson to the Asbury Park Press regarding their series on the dirty reality of Johnson and Johnson.
william, bill, weldon, ceo, pharma, scandal, corruption
 
William Weldon's $143.5 million Retirement Package (2012, March 22)
Okayyy, how about the high cost of healthcare? R&D? Yeah, right.
jnj, johnson and johnson, johnson + johnson, J&J, william, weldon, retirement, package
 
 
All contents Copyright © 2012-2016 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries